Variation in Phototherapy Treatment in Some Selected Hospitals in Ghana
Main Article Content
Keywords
Neonatal jaundice, Hyperbilirubinemia, Health care professionals, American Academy of Pediatrics
Abstract
Background: Neonatal jaundice (NNJ), one of the major diseases among neonates, could lead to Kernicterus (brain damage) if not treated well and early. The most significant treatment modality in the management of NNJ is phototherapy (PT). Providing PT by using clinical standards can enhance its effectiveness and safety and minimize PT-related complications. However, research shows that PT has not always been utilized in healthcare settings with low resources, and there is an incomplete understanding of NNJ and the use of PT for its management among trained community health workers (CHWs) and local communities. Objectives: The study aims to provide a basis for standardizing the use of PT to improve practice in Ghana. This was achieved by visiting selected hospitals in Ghana to acquire information on the use of PT and assessing the approach by which PT is administered by health professionals. Methods: The research utilized a descriptive cross-sectional design. Data were gathered using a Likert scale structured questionnaire. In addition, the Chi-square test of independence was used to establish the correlation between sociodemographic characteristics and health care workers’ perspectives on PT treatment. Data analysis was performed using SPSS, and a p-value of 0.05 or less indicates a significant relationship. Results: The study revealed that over half of the participants had a good attitude toward clinical presentation, emphasizing the importance of always testing for bilirubin levels before administering PT treatment. The majority of respondents also demonstrated a good understanding of the importance of calibrating and maintaining PT devices. Lastly, most participants had good knowledge of standard protocols and held a positive attitude toward PT treatment. Conclusions: NNJ is prevalent, and PT has become the gold standard method for treating both full-term and preterm infants affected by it. Therefore, we recommend that other health care facilities assess the effectiveness of their PT devices and follow standard procedures to enhance the efficacy of this treatment.
Downloads
Abstract 37 | PDF Downloads 8
References
2. Lawn,J.E., Blencowe, H., Oza. S., et al. Every Newborn: Progress, priorities, and potential beyond Survival. Lancet. 2014;384(9938):189–205. https://doi.org/10.1016/S0140-6736(14)60496-7.
3. Satrom,K.M., Farouk, Z.L., Slusher, T.M. Management challenges in the treatment of severe hyperbilirubinemia in low- and middle-income countries: Encouraging advancements, remaining gaps, and future opportunities. Front Pediatr. 2023;11(February):1–9. https://doi.org/10.3389/fped.2023.1001141.
4. Hulzebos, C.V., Camara, J.E., Van Berkel, M., et al. Bilirubin measurements in neonates: Uniform neonatal treatment can only be achieved by improved standardization. Clin Chem Lab Med. 2024;62(10):1892–903. https://doi.org/10.1515/cclm-2024-0620.
5. Bjerre, J.V., Petersen, J.R., Ebbesen, F. Surveillance of extreme hyperbilirubinaemia in Denmark. A method to identify the newborn infants. Acta Paediatr. 2008;97(8):1030–4. https://doi.org/10.1111/j.1651-2227.2008.00879.x.
6. McGillivray, A. and Evans, N. Severe neonatal jaundice: Is it a rare event in Australia? J Paediatr Child Health. 2012;48(9):801–7. https://doi.org/10.1111/j.1440-1754.2011.02217.x.
7. GBD 2013 Mortality and Causes of Death Collaborators.Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;385(9963):117–71. https://doi.org/10.1016/S0140-6736(14)61682-2.
8. Moseley,H., Allan, D., Amatiello, H, et al. Guidelines on the measurement of ultraviolet radiation levels in ultraviolet phototherapy: Report issued by the British Association of Dermatologists and British Photodermatology Group 2015. Br J Dermatol. 2015;173(2):333–50. https://doi.org/10.1111/bjd.13937.
9. American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics. 2004;114(1):297–316. https://doi.org/10.1542/peds.114.1.297.
10. Vreman,H.J., Wong, R.J., Stevenson, D.K. Phototherapy: Current methods and future directions. Semin Perinatol. 2004;28(5):326–33. https://doi.org/10.1053/j.semperi.2004.09.003.
11. American Academy of Pediatrics, Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics. 2004;114(1):297–316. https://doi.org/10.1542/peds.114.1.297.
12. Seidman. D.S., Moise, J., Ergaz, Z, et al. A prospective randomized controlled study of phototherapy using blue and blue-green light-emitting devices, and conventional halogen-quartz phototherapy. J Perinatol. 2003;23(2):123–7. https://doi.org/10.1038/sj.jp.7210862.
13. McDonagh, A.F. Phototherapy: From ancient egypt to the new millennium. J Perinatol. 2001;21:S7–12. https://doi.org/10.1038/sj.jp.7210625.
14. Adatara, P., Afaya, A., Salia, S.M., et al. Risk Factors Associated with Neonatal Sepsis: A Case Study at a Specialist Hospital in Ghana. Sci World J. 2019;2019:0–2. https://doi.org/10.1155/2019/9369051.
15. Elikplim Pomevor, K. and Adomah-Afari, A. Health providers’ perception of quality of care for neonates in health facilities in a municipality in Southern Ghana. Int J Health Care Qual Assur. 2016;29(8):907–20. https://doi.org/10.1108/IJHCQA-04-2016-0055.
16. Kemper, A.R., Newman, T.B., Slaughter, J.L., et al. Clinical Practice Guideline Revision: Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation. Pediatrics. 2022;150(3). https://doi.org/10.1542/peds.2022-058859.
17. Abdellatif, M., Tawfik, G.M., Makram, A.M., et al. Association between neonatal phototherapy and future cancer: an updated systematic review and meta-analysis. Eur J Pediatr. 2022;182(1):329–341. https://doi.org/10.1007/s00431-022-04675-6.
18. Abdulkadir, I. and Slusher, T.M. Neonatal Eye Shielding during Phototherapy: What Protects the Eye Better? J Trop Pediatr. 2021;67(6):1–4. https://doi.org/10.1093/tropej/fmab101.
19. Elsayed Amin H, Dardier Hussein Awad R, Mahmoud Elrefaey N, Gamal Mohamed M. Effect of Implementing Educational Guidelines on Nurses’ Knowledge and Practice toward Caring of Vitiligo Patients Undergoing of Photo Therapy. Egypt J Heal Care. 2024;15(1):1464–80. https://doi.org/10.21608/ejhc.2024.346787.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
Author(s) must obtain all parties consent [co-author(s), others if applicable] and submit the acceptance of Copyright Agreement with their paper. Written permission must be obtained by the author for material that has been published in copyrighted material; this includes tables, figures, and quoted text that exceeds 150 words. A copy of all permissions must accompany the manuscript when published in copyrighted material. The author(s) hereby represents and warrants that the paper is original and that he/she is the author of the paper, except for material that is clearly identified as to its original source, with permission notices from the copyright owners where required. Author(s) must clearly indicate that approval for publication has been received in cases of institutional ownership.
In all submitted material authors retain all copyrights; however, the GlobalCE Journal reserve the right to reprint all or portions of the article and to post all or part of the article online. GlobalCE Journal reserves the right to edit manuscripts as required to publish in the journal. Authors are responsible for obtaining any and all clearances as appropriate. Unless stated otherwise, all articles are open-access and distributed under the terms of the Creative Commons Attribution License (CC BY 4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original author(s) and original work (e.g. first published in the Global Clinical Engineering Journal) is properly cited with the original URL and bibliographic citation information. The complete bibliographic information, a link to the original publication on www.Globalce.org well as the copyright and license information must be included. No use, distribution or reproduction is permitted which does not comply with these terms.
